Darleukin, Fibromun clinical trials

A Phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions.

This study is investigating a new treatment for certain skin cancers that have not spread. It uses two special medications, Darleukin and Fibromun, injected directly into the skin cancer. It aims to see how well these medications shrink or get rid of the cancer.